Archer Investment Corp Buys 935 Shares of CME Group Inc. $CME

Archer Investment Corp lifted its position in CME Group Inc. (NASDAQ:CME - Free Report) by 3,596.2% in the second quarter, according to its most recent Form 13F filing with the SEC. The firm owned 961 shares of the financial services provider's stock after purchasing an additional 935 shares during the period. Archer Investment Corp's holdings in CME Group were worth $265,000 at the end of the most recent quarter.

• Capitalize on Volatility: 3 Finance Stocks Thriving in 2025

Several other hedge funds and other institutional investors also recently bought and sold shares of CME. Webster Bank N. A. grew its position in shares of CME Group by 206.9% during the 2nd quarter. Webster Bank N. A. now owns 89 shares of the financial services provider's stock worth $25,000 after buying an additional 60 shares in the last quarter. Highline Wealth Partners LLC raised its holdings in shares of CME Group by 84.3% in the second quarter. Highline Wealth Partners LLC now owns 94 shares of the financial services provider's stock valued at $26,000 after acquiring an additional 43 shares in the last quarter. Ransom Advisory Ltd purchased a new stake in CME Group in the first quarter worth about $31,000. Trifecta Capital Advisors LLC grew its holdings in CME Group by 59.2% during the 2nd quarter. Trifecta Capital Advisors LLC now owns 113 shares of the financial services provider's stock worth $31,000 after acquiring an additional 42 shares in the last quarter. Finally, Westside Investment Management Inc. grew its holdings in CME Group by 105.0% during the 2nd quarter. Westside Investment Management Inc. now owns 123 shares of the financial services provider's stock worth $34,000 after acquiring an additional 63 shares in the last quarter. Institutional investors own 87.75% of the company's stock.

Insider Transactions at CME Group

In related news, Director Harold Eugene Jr. Ford sold 1,000 shares of the firm's stock in a transaction on Monday, November 3rd. The stock was sold at an average price of $263.53, for a total value of $263,530.00. Following the completion of the transaction, the director owned 1,091 shares in the company, valued at $287,511.23. This trade represents a 47.82% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, insider Timothy Francis Mccourt sold 379 shares of the business's stock in a transaction dated Tuesday, September 16th. The shares were sold at an average price of $259.83, for a total value of $98,475.57. Following the sale, the insider owned 9,508 shares in the company, valued at approximately $2,470,463.64. The trade was a 3.83% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 14,043 shares of company stock worth $3,791,486 over the last 90 days. Insiders own 0.30% of the company's stock.

CME Group Stock Performance

• Morgan Stanley: 3 Financial Stocks That Will Thrive in Volatility

Shares of CME Group stock opened at $275.21 on Friday. The company has a 50 day moving average price of $268.53 and a 200 day moving average price of $272.84. The firm has a market capitalization of $99.24 billion, a P/E ratio of 26.67, a PEG ratio of 4.41 and a beta of 0.38. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.12. CME Group Inc. has a 52 week low of $224.62 and a 52 week high of $290.79.

CME Group (NASDAQ:CME - Get Free Report) last released its earnings results on Wednesday, October 22nd. The financial services provider reported $2.68 earnings per share for the quarter, topping the consensus estimate of $2.63 by $0.05. The company had revenue of $1.54 billion for the quarter, compared to the consensus estimate of $1.56 billion. CME Group had a net margin of 58.84% and a return on equity of 14.61%. CME Group's revenue was down 3.0% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $2.68 EPS. Sell-side analysts expect that CME Group Inc. will post 10.49 EPS for the current year.

CME Group Announces Dividend

• 4 Stocks Planning to Return Capital With Hefty Buyback Programs

The company also recently announced a quarterly dividend, which will be paid on Tuesday, December 30th. Investors of record on Friday, December 12th will be given a $1.25 dividend. This represents a $5.00 annualized dividend and a dividend yield of 1.8%. The ex-dividend date of this dividend is Friday, December 12th. CME Group's dividend payout ratio is presently 48.45%.

Analyst Upgrades and Downgrades

CME has been the subject of several research reports. Citigroup raised shares of CME Group from a "neutral" rating to a "buy" rating and upped their price target for the stock from $275.00 to $300.00 in a research report on Thursday, September 25th. TD Cowen boosted their price objective on shares of CME Group from $288.00 to $290.00 and gave the stock a "hold" rating in a research note on Thursday, October 23rd. Deutsche Bank Aktiengesellschaft increased their target price on CME Group from $300.00 to $310.00 and gave the company a "buy" rating in a research report on Friday, November 14th. The Goldman Sachs Group lifted their price target on CME Group from $262.00 to $263.00 and gave the company a "sell" rating in a report on Thursday, October 23rd. Finally, Barclays decreased their price objective on CME Group from $298.00 to $280.00 and set an "equal weight" rating for the company in a research note on Wednesday, October 8th. Eight research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and three have issued a Sell rating to the company's stock. Based on data from MarketBeat, the company has a consensus rating of "Hold" and an average target price of $287.65.

Check Out Our Latest Research Report on CME

About CME Group

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Recommended Stories

• Five stocks we like better than CME Group
• Health Care Stocks Explained: Why You Might Want to Invest
• Datavault AI Just Raised Guidance by 400%—Are You Paying Attention?
• How to Invest in the Best Canadian Stocks
• Peter Thiel Dumps NVIDIA and Slashes Tesla Stake—Is the AI Bubble About to Pop?
• 3 Natural Gas Stocks That Offer Great Dividend Yields
• Why Lithium Americas Could Be a 2030 Power Play—Not a 2025 One

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in CME Group Right Now?

Before you consider CME Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CME Group wasn't on the list.

While CME Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here